Cargando…
Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation
Opioid-induced constipation (OIC) is one of the most troublesome and the most common effects of opioid use leading to deterioration in quality of life of the patients and also has potentially deleterious repercussions on adherence and compliance to opioid therapy. With the current guidelines advocat...
Autores principales: | Anantharamu, Tejus, Sharma, Sushil, Gupta, Ajay Kumar, Dahiya, Navdeep, Singh Brashier, Dick B., Sharma, Ashok Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544149/ https://www.ncbi.nlm.nih.gov/pubmed/26312011 http://dx.doi.org/10.4103/0976-500X.162015 |
Ejemplares similares
-
Macitentan: An important addition to the treatment of pulmonary arterial hypertension
por: Khadka, Anjan, et al.
Publicado: (2015) -
Lorcaserin: A novel antiobesity drug
por: Brashier, Dick B. S., et al.
Publicado: (2014) -
Boceprevir: A new hope against hepatitis C virus
por: Brashier, Dick B. S., et al.
Publicado: (2012) -
Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015) -
Fingolimod (FTY720): First approved oral therapy for multiple sclerosis
por: Sharma, Sushil, et al.
Publicado: (2011)